Evidence map›Paper›PMID 39253949›Full record

ArticleGeriatrics & gerontology international2024

Diagnosis of sarcopenic obesity in Japan: Consensus statement of the Japanese Working Group on Sarcopenic Obesity.

Kojiro Ishii, Wataru Ogawa, Yutaka Kimura, Toru Kusakabe, Ryo Miyazaki, Kiyoshi Sanada, Noriko Satoh-Asahara, Yuki Someya, Yoshifumi Tamura, Kohjiro Ueki and 4 more

Abstract readConsensus Statement
In one paragraph

Article in Geriatrics & gerontology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kojiro IshiiFaculty of Health and Sports Science, Doshisha University, Kyotanabe, Japan.ORCID https://orcid.org/0000-0002-3310-9470
Wataru OgawaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID https://orcid.org/0000-0002-0432-4366
Yutaka KimuraHealth Science Center, Kansai Medical University, Hirakata, Japan.ORCID https://orcid.org/0000-0002-9607-0980
Toru KusakabeDepartment of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.ORCID https://orcid.org/0000-0001-8644-3539
Ryo MiyazakiFaculty of Human Sciences, Shimane University, Matsue, Japan.ORCID https://orcid.org/0000-0002-1996-709X
Kiyoshi SanadaFaculty of Sport and Health Science, Ritsumeikan University, Kusatsu, Japan.ORCID https://orcid.org/0000-0003-3703-4098
Noriko Satoh-AsaharaDepartment of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.ORCID https://orcid.org/0000-0002-8645-3144
Yuki SomeyaSportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yoshifumi TamuraSportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-1685-7821
Kohjiro UekiDiabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-1523-8102
Hidetaka WakabayashiDepartment of Rehabilitation Medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-0364-0818
Yuya WatanabeFaculty of Sport Study, Biwako Seikei Sport College, Otsu, Japan.ORCID https://orcid.org/0000-0003-3970-1202
Minoru YamadaFaculty of Human Sciences, University of Tsukuba, Tsukuba, Japan.ORCID https://orcid.org/0000-0003-3291-0175
Hidenori AraiNational Center for Geriatrics and Gerontology, Obu, Japan.ORCID https://orcid.org/0000-0002-9000-6849

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcopenic obesity is the co-existence of obesity and sarcopenia in individuals aged 40-75 years. The Japanese Working Group on Sarcopenic Obesity has developed diagnostic criteria tailored for the Japanese population, considering their unique characteristics compared with European populations. Our algorithm consists of two steps: screening and diagnosis. The screening of obesity mandates using waist circumference and/or body mass index (BMI) based on national standards, while screening for sarcopenia involves the "finger ring test" in addition to the Asian Working Group for Sarcopenia 2019 criteria. The final diagnosis of sarcopenia involves handgrip strength for low muscle strength, the five-times chair stand test for low physical function, and limb skeletal muscle mass (corrected for BMI) for low muscle mass. Obesity is assessed by visceral fat area or body fat percentage. Sarcopenic obesity is then categorized into Stage I, with muscle weakness/loss of function, loss of muscle mass, and obesity; or Stage II, which includes complications. Further clinical validation is needed to refine the consensus and age range. Geriatr Gerontol Int 2024; 24: 997-1000.

Indexed as

ConsensusObesitySarcopeniaAdultAgedBody Mass IndexEast Asian PeopleFemaleHand StrengthHumansJapanMaleMass ScreeningMiddle AgedWaist Circumferencealgorithmdefinitiondiagnostic criteriasarcopenic obesity

Identifiers

PMID39253949
PMCPMC11503547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.